These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. 1-(Theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (ML 1024), a new hypolipemic agent. Metz G; Specker M; Sterner W; Heisler E; Grahwit G Arzneimittelforschung; 1977; 27(6):1173-7. PubMed ID: 578436 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of new clofibrate analogues as potential PPARalpha agonists. Perrone MG; Santandrea E; Dell'Uomo N; Giannessi F; Milazzo FM; Sciarroni AF; Scilimati A; Tortorella V Eur J Med Chem; 2005 Feb; 40(2):143-54. PubMed ID: 15694649 [TBL] [Abstract][Full Text] [Related]
29. Ethyl 2-([5,6-dihydro-7-(1H-imidazol-1-yl)-2-naphthalenyl]oxy)- 2-methylpropanoate as a new potent oxyisobutyrate hypolipidaemic with unusual features. Cozzi P; Branzoli U; Carganico G; Chiari A; Lovisolo PP; Severino D Farmaco Sci; 1987 Mar; 42(3):205-18. PubMed ID: 3653387 [TBL] [Abstract][Full Text] [Related]
30. Structure/activity relationship of gemfibrozil (CI-719) and related compounds. Creger PL; Moersch GW; Neuklis WA Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):3-5. PubMed ID: 1019152 [No Abstract] [Full Text] [Related]
31. [Clinical effects and tolerance of etofylline clofibrate]. Ziegler WJ; Metz G; Specker M Arzneimittelforschung; 1980; 30(11b):2053-8. PubMed ID: 7194059 [TBL] [Abstract][Full Text] [Related]
32. Studies on antihyperlipidemic agents. II. Synthesis and biological activities of 2-chloro-3-arylpropionic acids. Kawamatsu Y; Asakawa H; Saraie T; Imamiya E; Nishikawa K; Hamuro Y Arzneimittelforschung; 1980; 30(4):585-9. PubMed ID: 7190396 [TBL] [Abstract][Full Text] [Related]
33. Potential hypolipidemic agents. XII. Synthesis and plasma lipid-lowering properties of some 3-pyridylmethyl ethers. Bondesson G; Hedbom C; Magnusson O; Stjernström NE Acta Pharm Suec; 1975; 12(5-6):445-54. PubMed ID: 1217497 [No Abstract] [Full Text] [Related]
34. The hypolipidaemic effect of gemfibrozil (CI-719) in laboratory animals. Rodney G; Uhlendorf P; Maxwell RE Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):6-10. PubMed ID: 828263 [No Abstract] [Full Text] [Related]
35. [Chemistry of phenoxyacetic acid esters of oxyalkyltheophyllines and 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methyl-propionate] (etofylline clofibrate), a novel antilipaemic agent (author's transl)]. Metz G; Specker M Arzneimittelforschung; 1980; 30(11b):2014-9. PubMed ID: 7194051 [TBL] [Abstract][Full Text] [Related]
36. Influence of various central moieties on the hypolipidemic properties of long hydrocarbon chain diols and diacids. Oniciu DC; Dasseux JL; Yang J; Mueller R; Pop E; Denysenko A; Duan C; Huang TB; Zhang L; Krause BR; Drake SL; Lalwani N; Cramer CT; Goetz B; Pape ME; McKee A; Fici GJ; Lutostanski JM; Brown SC; Bisgaier CL J Med Chem; 2006 Jan; 49(1):334-48. PubMed ID: 16392818 [TBL] [Abstract][Full Text] [Related]
37. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] on lipid metabolism. I. Effect on blood lipids in normal and hyperlipemic rats]. Maroto ML; Priego JG; Piña M; Catalán RE Arch Farmacol Toxicol; 1978 Apr; 4(1):25-7. PubMed ID: 697396 [No Abstract] [Full Text] [Related]
38. Synthesis and pharmacological study of antihyperlipaemic activity of 2-substituted thieno(2,3-d)pyrimidin-4(3H)-ones. Shishoo CJ; Devani MB; Bhadti VS; Jain KS; Rathod IS; Goyal RK; Gandhi TP; Patel RB; Naik SR Arzneimittelforschung; 1990 May; 40(5):567-72. PubMed ID: 2383297 [TBL] [Abstract][Full Text] [Related]
39. [Effect on lipidemia in the rat of bis-homoanalogs of adenine nucleosides]. Gaggi R; Giovanninetti G; Cavrini V; Garuti L; Roveri P; Amorosa M; Defaye J Farmaco Sci; 1980 Jul; 35(7):581-9. PubMed ID: 7450047 [TBL] [Abstract][Full Text] [Related]